Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Function and Immunochemistry of Prekallikrein-High Molecular Weight Kininogen Complex in Plasma
Cheryl F. Scott, Robert W. Colman
Cheryl F. Scott, Robert W. Colman
Published February 1, 1980
Citation Information: J Clin Invest. 1980;65(2):413-421. https://doi.org/10.1172/JCI109684.
View: Text | PDF
Research Article

Function and Immunochemistry of Prekallikrein-High Molecular Weight Kininogen Complex in Plasma

  • Text
  • PDF
Abstract

Plasma from individuals with high molecular weight (HMW) kininogen deficiency has been reported to be deficient in prekallikrein as measured by radial immunodiffusion, prekallikrein coagulant activity, and/or kaolin-activated arginine esterase activity. The discovery that prekallikrein and HMW kininogen circulate as a complex in plasma led us to reevaluate the antigenic and functional properties of prekallikrein in HMW kininogen-deficient plasma as well as in normal plasma.

Authors

Cheryl F. Scott, Robert W. Colman

×

Total citations by year

Year: 2022 2021 2020 2019 2016 2014 2013 2012 2011 2010 2009 2003 2002 1998 1994 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 1981 1968 Total
Citations: 3 3 1 1 3 4 2 2 1 3 2 3 2 1 2 1 3 5 2 2 2 3 3 3 4 3 3 1 68
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (68)

Title and authors Publication Year
Blocking domain 6 of high molecular weight kininogen to understand intrinsic clotting mechanisms.
Singh PK, Chen ZL, Horn K, Norris EH
Research and Practice in Thrombosis and Haemostasis 2022
The complex role of kininogens in hereditary angioedema.
Kaplan AP, Joseph K, Ghebrehiwet B
2022
The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis.
Fijen LM, Petersen RS, Meijers JCM, Bordone L, Levi M, Cohn DM
Thrombosis and haemostasis 2022
Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema
S de Maat, K Joseph, C Maas, AP Kaplan
Clinical Reviews in Allergy & Immunology 2021
Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing
R Gindele, A Kerényi, J Kállai, G Pfliegler, Á Schlammadinger, I Szegedi, T Major, Z Szabó, Z Bagoly, C Kiss, J Kappelmayer, Z Bereczky
Life Sciences 2021
Pathophysiology and underlying mechanisms in hereditary angioedema.
López Lera A
Balkan Medical Journal 2021
Severe high-molecular-weight kininogen deficiency due to a homozygous c.1456C > T nonsense variant in a large Chinese family
J Yang, L Fan, Y Qiao, Y Zhao, T Zhu
Journal of Thrombosis and Thrombolysis 2020
Plasma kallikrein contributes to ambient particulate matter-induced lung injury
B Wang, X Yan, F Chen, A Yang, Y Lu, Y Wu
Biochemical and Biophysical Research Communications 2019
Complement, Kinins, and Hereditary Angioedema: Mechanisms of Plasma Instability when C1 Inhibitor is Absent
AP Kaplan, K Joseph
Clinical Reviews in Allergy & Immunology 2016
Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity
JL Mitchell, AS Lionikiene, G Georgiev, A Klemmer, C Brain, PY Kim, NJ Mutch
Blood 2016
A Cross-sectional Study of KLKB1 and PRCP Polymorphisms in Patient Samples with Cardiovascular Disease
HR Gittleman, A Merkulova, O Alhalabi, EX Stavrou, ML Veigl, JS Barnholtz-Sloan, AH Schmaier
Frontiers in Medicine 2016
Reduced thrombosis in Klkb1-/- mice is mediated by increased Mas receptor, prostacyclin, Sirt1, and KLF4 and decreased tissue factor
EX Stavrou, C Fang, A Merkulova, O Alhalabi, N Grobe, S Antoniak, N Mackman, AH Schmaier
Blood 2014
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Tracking down contact activation - from coagulation in vitro to inflammation in vivo
S Maat, C Tersteeg, E Herczenik, C Maas
International Journal of Laboratory Hematology 2014
Bacteria under stress by complement and coagulation
ET Berends, A Kuipers, MM Ravesloot, RT Urbanus, SH Rooijakkers
FEMS Microbiology Reviews 2014
The kinin–kallikrein system: physiological roles, pathophysiology and its relationship to cancer biomarkers
E Kashuba, J Bailey, D Allsup, L Cawkwell
Biomarkers 2013
Factor XII–independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II
K Joseph, BG Tholanikunnel, A Bygum, B Ghebrehiwet, AP Kaplan
Journal of Allergy and Clinical Immunology 2013
Structural Requirements for the Procoagulant Activity of Nucleic Acids
J Gansler, M Jaax, S Leiting, B Appel, A Greinacher, S Fischer, KT Preissner, MP Bachmann
PloS one 2012
Methods in Enzymology
JD Stone, AS Chervin, DH Aggen, DM Kranz
Protein Engineering for Therapeutics Part B 2012
Advances in Immunology
E Pinaud, M Marquet, R Fiancette, S Péron, C Vincent-Fabert, Y Denizot, M Cogné
Advances in Immunology Volume 110 2011
Structure and function of factor XI
J Emsley, PA McEwan, D Gailani
Blood 2010
Congenital prekallikrein deficiency
A Girolami, P Scarparo, N Candeo, AM Lombardi
Expert Review of Hematology 2010
xPharm: The Comprehensive Pharmacology Reference
A Vinh
xPharm: The Comprehensive Pharmacology Reference 2010
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009
Factor XII–independent cleavage of high-molecular-weight kininogen by prekallikrein and inhibition by C1 inhibitor
K Joseph, BG Tholanikunnel, AP Kaplan
Journal of Allergy and Clinical Immunology 2009
Characterization of molecular defects of Fitzgerald trait and another novel high-molecular-weight kininogen-deficient patient: insights into structural requirements for kininogen expression
Y Krijanovski
Blood 2003
Human Kininogen Gene Is Transactivated by the Farnesoid X Receptor
A Zhao, JL Lew, L Huang, J Yu, T Zhang, Y Hrywna, JR Thompson, N Pedro, RA Blevins, F Peláez, SD Wright, J Cui
The Journal of biological chemistry 2003
Factor XI, but Not Prekallikrein, Blocks High Molecular Weight Kininogen Binding to Human Umbilical Vein Endothelial Cells
TR Baird, PN Walsh
The Journal of biological chemistry 2003
Chronic intestinal inflammation and angiogenesis in genetically susceptible rats is modulated by kininogen deficiency
I Isordia-Salas, RA Pixley, F Li, I Sainz, RB Sartor, A Adam, RW Colman
International Immunopharmacology 2002
Kininogen deficiency modulates chronic intestinal inflammation in genetically susceptible rats
I Isordia-Salas, RA Pixley, F Li, I Sainz, RB Sartor, A Adam, RW Colman
AJP Gastrointestinal and Liver Physiology 2002
High Molecular Weight Kininogen Regulates Prekallikrein Assembly and Activation on Endothelial Cells: A Novel Mechanism for Contact Activation
G Motta, R Rojkjaer, AA Hasan, DB Cines, AH Schmaier
Blood 1998
Significance of the Regulation of Plasma Kallikrein by ?2M
RW Colman
Annals of the New York Academy of Sciences 1994
The shape of high molecular weight kininogen. Organization into structural domains, changes with activation, and interactions with prekallikrein, as determined by electron microscopy
JW Weisel, C Nagaswami, JL Woodhead, RA Cadena, JD Page, RW Colman
The Journal of biological chemistry 1994
Domain 3 of kininogens contains a cell-binding site and a site that modifies thrombin activation of platelets
YP Jiang, W Muller-Esterl, AH Schmaier
The Journal of biological chemistry 1992
Contact activation factors in plasma from pregnant women-increased level of an association between factor XII and kallikrein
K Briseid, NO Hoem, S Johannesen, S Fossum
Thrombosis Research 1991
Low molecular weight kininogen binds to platelets to modulate thrombin-induced platelet activation
FJ Meloni, AH Schmaier
The Journal of biological chemistry 1991
Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371)
JD Page, RW Colman
The Journal of biological chemistry 1991
The inositol-phospholipid-accelerated activation of prekallikrein by activated factor XII at physiological ionic strength requires zinc ions and high-Mr kininogen
I SCHOUSBOE
European Journal of Biochemistry 1990
Functional correlation between kallikrein and factor XII activated in human plasma
K Briseid, NO Hoem, S Johannesen, K Marthinsen
Thrombosis Research 1990
A new case of total kininogen deficiency
H Stormorken, K Briseid, B Hellum, NO Hoem, HT Johansen, B Ly
Thrombosis Research 1990
1 Mechanism of heparin action
CM Jackson
Baillière's Clinical Haematology 1990
6 Mechanism of action of the thrombolytic agents
JI Weitz
Baillière's Clinical Haematology 1990
Human neutrophils contain and bind high molecular weight kininogen
EJ Gustafson, AH Schmaier, YT Wachtfogel, N Kaufman, U Kucich, RW Colman
Journal of Clinical Investigation 1989
Kinins V
K Abe, H Moriya, S Fujii
1989
A Prospective Study of Platelets and Plasma Proteolytic Systems during the Early Stages of Rocky Mountain Spotted Fever
AK Rao, M Schapira, ML Clements, S Niewiarowski, AZ Budzynski, AH Schmaier, PC Harpel, WC Blackwelder, JR Scherrer, E Sobel, RW Colman
New England Journal of Medicine 1988
The expression of high molecular weight kininogen on human umbilical vein endothelial cells
AH Schmaier, A Kuo, D Lundberg, S Murray, DB Cines
The Journal of biological chemistry 1988
Initiation of Blood Coagulation at Artificial Surfaces
RW Colman, CF Scott, AH Schmaier, YT Wachtfogel, RA Pixley, LH Edmunds
Annals of the New York Academy of Sciences 1987
Determination of the bifunctional properties of high molecular weight kininogen by studies with monoclonal antibodies directed to each of its chains
AH Schmaier, D Schutsky, A Farber, LD Silver, HN Bradford, RW Colman
The Journal of biological chemistry 1987
The contact activation system: Biochemistry and interactions of these surface-mediated defense reactions
RW Colman, AH Schmaier, OD Ratnoff
Critical Reviews in Oncology/Hematology 1986
A new case of high-molecular-weight kininogen inherited deficiency
JJ Lefrère, MH Horellou, D Gozin, J Conard, JY Muller, M Clark, JP Soulier, M Samama
American Journal of Hematology 1986
Kinins IV
LM Greenbaum, HS Margolius
1986
Antibodies to human plasma kallikrein from egg yolks of an immunized hen: Preparation and characterization
D Burger, MA Ramus, M Schapira
Thrombosis Research 1985
Immunology of Rheumatic Diseases
S Gupta, N Talal
1985
Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains
PE Bock, JD Shore, G Tans, JH Griffin
The Journal of biological chemistry 1985
Surface-mediated defense reactions. The plasma contact activation system
RW Colman
Journal of Clinical Investigation 1984
The effect of high molecular weight kininogen on surface-adsorbed fibrinogen
AH Schmaier, L Silver, AL Adams, GC Fischer, PC Munoz, L Vroman, RW Colman
Thrombosis Research 1984
Interaction of human plasma kallikrein and its light chain with .alpha.2-macroglobulin
FV der Graaf, A Rietveld, FJ Keus, BN Bouma
Biochemistry 1984
High-molecular weight kininogen. A secreted platelet protein
AH Schmaier, A Zuckerberg, C Silverman, J Kuchibhotla, GP Tuszynski, RW Colman
Journal of Clinical Investigation 1983
Prekallikrein Activation and High-Molecular-Weight Kininogen Consumption in Hereditary Angioedema
M Schapira, LD Silver, CF Scott, AH Schmaier, LJ Prograis, JG Curd, RW Colman
New England Journal of Medicine 1983
Interaction of human plasma kallikrein and its light chain with C.hivin.1 inhibitor
FV der Graaf, JA Koedam, JH Griffin, BN Bouma
Biochemistry 1983
The Physiology of Hemostasis
D Ogston
1983
Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen
CF Scott, M Schapira, HL James, AB Cohen, RW Colman
Journal of Clinical Investigation 1982
Immunoelectrophoretic studies of prekallikrein in human plasma
WE Hathaway, J Christian, R McGregor, C Borden
Thrombosis Research 1982
High molecular weight kininogen or its light chain protects human plasma kallikrein from inactivation by plasma protease inhibitors
M Schapira, CF Scott, A James, LD Silver, F Kueppers, HL James, RW Colman
Biochemistry 1982
REGULATION OF THE FORMATION AND INHIBITION OF HUMAN PLASMA KALLIKREIN*
RW Colman, M Schapira, CF Scott
Annals of the New York Academy of Sciences 1981
Heterogeneity of Human Prekallikrein Deficiency (Fletcher Trait): Evidence That Five of 18 Cases Are Positive for Cross-Reacting Material
H Saito, LT Goodnough, J Soria, C Soria, J Aznar, F España
New England Journal of Medicine 1981
Protection of human plasma kallikrein from inactivation by c.hivin.1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen
M Schapira, CF Scott, RW Colman
Biochemistry 1981
Blut und Blutkrankheiten
L Heilmeyer, K Betke, KG von Boroviczény, D Busch, E Grundmann, H Heimpel, G Hoffmann, W Hunstein, W Keiderling, M Matthes, H Merker, W Müller, P Pfannenstiel
1968

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts